The Centers for Disease Control and Prevention (CDC) recently released a Health Alert Network (HAN) alerting medical and public health professionals, first responders, harm reduction organizations, and other community partners that more than 81,000 drug overdose deaths occurred in the United States in the 12 months ending in May 2020. This is the highest number of overdose deaths ever recorded in a 12-month period. While overdose deaths were already increasing in the months preceding the 2019 novel coronavirus (COVID-19) pandemic, the latest numbers suggest an acceleration of overdose deaths during the pandemic. The HAN says synthetic opioids (primarily illicitly manufactured fentanyl) appear to be the primary driver of the increases.
New federal and state requirements for the electronic prescribing of controlled substances will take effect on Jan 1, 2021. However, the Indiana State Medical Association (ISMA) reports that the enforcement date for the federal Medicare e-prescribing requirement was recently extended by one year. In addition, the Indiana Board of Pharmacy has established a process to apply for waivers from the state electronic prescribing requirement. This waiver process is separate from the statutory exceptions that are available under the law. Read more about this on ISMA’s website.
The Centers for Disease Control and Prevention (CDC) released a suite of training tools and resources to help clinicians and healthcare executives apply the CDC Guideline for Prescribing Opioids for Chronic Pain in clinical settings. This includes a new interactive, online training module that highlights strategies for improving patient outcomes by reducing opioid administration and prescribing in the emergency department, as well as short videos on opioid tapering and risk factors. Click here to access the full suite of clinician training and resources.
|